Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

The hydrogel effectively treats oral mucositis by reducing oxidative damage and bacterial infection.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Engineered vesicles from macrophages help hair growth in mice and humans.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Hyaluronic acid microneedles help deliver minoxidil derivatives effectively for hair regrowth.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Patients with skin immune diseases need better education on UV protection to improve compliance.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Ocrelizumab may cause total body hair loss in some patients.